| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_891c826c3847707b41e038ec7974a809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bca06378a4a9c8654bfdb68413fb16bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ecfab6e20c75dffb28ac56bcdd001ce6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc5f5cc373364e5775f5eecdf3cab1cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c4322cb4de342be2dbedcbe0c278f6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1b635430efc96d00ad3f6e4d9eb7afd2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 |
| filingDate |
2006-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d2960616a9c38f84f4505584a015517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff3c12ccc4d93c1f56f6f4f642f45bf4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ccc0266bceceb22b305f46ae6a9072f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26c77c283a18b9fbe184000f6e4cf46f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dcb7e67c3bf62a2b237d6e9cb3c1d80 |
| publicationDate |
2007-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006133231-A3 |
| titleOfInvention |
Treatment for neurodegenerative diseases |
| abstract |
A method of treating a neurodegenerative disease in a subject in need thereof comprises: (a) administering the subject an ornithine decarboxylase inhibitor such as alpha-difluoromethylornithine or a pharmaceutically acceptable salt or prodrug thereof in an amount effective to treat the disease; and concurrently (b) administering the subject a polyamine or a pharmaceutically acceptable salt or prodrug thereof in an amount effective to reduce damage to the gastroinestinal tract of the subject by the ornithine decarboxylase inhibitor. |
| priorityDate |
2005-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |